{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T13:41:48Z","timestamp":1762004508278,"version":"3.40.4"},"reference-count":28,"publisher":"Frontiers Media SA","issue":"8","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":839,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Transpl Int"],"published-print":{"date-parts":[[2013,8]]},"DOI":"10.1111\/tri.12120","type":"journal-article","created":{"date-parts":[[2013,4,26]],"date-time":"2013-04-26T17:40:39Z","timestamp":1366998039000},"page":"e64-e68","source":"Crossref","is-referenced-by-count":8,"title":["Four-year allograft survival in a highly sensitized combined liver-kidney transplant patient despite unsuccessful anti-HLA antibody reduction with rituximab, splenectomy, and bortezomib"],"prefix":"10.3389","volume":"26","author":[{"given":"Martina","family":"Koch","sequence":"first","affiliation":[{"name":"Department of Hepatobiliary and Transplant Surgery; University Medical Center Hamburg-Eppendorf (UKE); Hamburg; Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Gr\u00e4ser","sequence":"additional","affiliation":[{"name":"Department of Hepatobiliary and Transplant Surgery; University Medical Center Hamburg-Eppendorf (UKE); Hamburg; Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anja","family":"Lehnhardt","sequence":"additional","affiliation":[{"name":"Department of Hepatobiliary and Transplant Surgery; University Medical Center Hamburg-Eppendorf (UKE); Hamburg; Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00f6rg M.","family":"Pollok","sequence":"additional","affiliation":[{"name":"Department of Hepatobiliary and Transplant Surgery; University Medical Center Hamburg-Eppendorf (UKE); Hamburg; Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nikolaus","family":"Kr\u00f6ger","sequence":"additional","affiliation":[{"name":"Bone Marrow Transplantation Unit UKE; Hamburg; Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Murielle","family":"Verboom","sequence":"additional","affiliation":[{"name":"Institute for Transfusion Medicine; Hannover Medical School; Hannover; Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Friedrich","family":"Thaiss","sequence":"additional","affiliation":[{"name":"Department of Nephrology; Internal Medicine III UKE; Hamburg; Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Eiermann","sequence":"additional","affiliation":[{"name":"Department for Transfusion Medicine; HLA Laboratory UKE; Hamburg; Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bj\u00f6rn","family":"Nashan","sequence":"additional","affiliation":[{"name":"Department of Hepatobiliary and Transplant Surgery; University Medical Center Hamburg-Eppendorf (UKE); Hamburg; Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2013,5,15]]},"reference":[{"key":"10.1111\/tri.12120-BIB0001|tri12120-cit-0001","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1097\/00007890-200204270-00014","article-title":"Kidney graft failure and presensitization against HLA class I and class II antigens","volume":"73","author":"Susal","year":"2002","journal-title":"Transplantation"},{"key":"10.1111\/tri.12120-BIB0002|tri12120-cit-0002","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1111\/j.1600-6143.2006.01721.x","article-title":"The importance of anti-HLA-specific antibody strength in monitoring kidney transplant patients","volume":"7","author":"Mizutani","year":"2007","journal-title":"Am J Transplant"},{"key":"10.1111\/tri.12120-BIB0003|tri12120-cit-0003","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1111\/j.1600-6143.2006.01592.x","article-title":"Successful combined partial auxiliary liver and kidney transplantation in highly sensitized cross-match positive recipients","volume":"7","author":"Olausson","year":"2007","journal-title":"Am J Transplant"},{"key":"10.1111\/tri.12120-BIB0004|tri12120-cit-0004","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1097\/00007890-200104270-00025","article-title":"Significance of a T-lymphocytotoxic crossmatch in liver and combined liver-kidney transplantation","volume":"71","author":"Neumann","year":"2001","journal-title":"Transplantation"},{"key":"10.1111\/tri.12120-BIB0005|tri12120-cit-0005","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1002\/lt.23534","article-title":"Progressive graft fibrosis and donor-specific HLA antibodies in pediatric late liver allografts","volume":"18","author":"Miyagawa-Hayashino","year":"2012","journal-title":"Liver Transpl"},{"key":"10.1111\/tri.12120-BIB0006|tri12120-cit-0006","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1111\/j.1600-6143.2010.03414.x","article-title":"The significance of donor-specific HLA antibodies in rejection and ductopenia development in ABO compatible liver transplantation","volume":"11","author":"Musat","year":"2011","journal-title":"Am J Transplant"},{"key":"10.1111\/tri.12120-BIB0007|tri12120-cit-0007","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1111\/j.1600-6143.2011.03593.x","article-title":"High mean fluorescence intensity donor-specific anti-HLA antibodies associated with chronic rejection post-liver transplant","volume":"11","author":"O'Leary","year":"2011","journal-title":"Am J Transplant"},{"key":"10.1111\/tri.12120-BIB0008|tri12120-cit-0008","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1097\/TP.0b013e3182184181","article-title":"Combined liver-kidney transplants: allosensitization and recipient outcomes","volume":"91","author":"Askar","year":"2011","journal-title":"Transplantation"},{"key":"10.1111\/tri.12120-BIB0009|tri12120-cit-0009","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1007\/s00467-012-2142-8","article-title":"Elevated serum levels of B-cell activating factor in pediatric renal transplant patients","volume":"27","author":"Lehnhardt","year":"2012","journal-title":"Pediatr Nephrol"},{"key":"10.1111\/tri.12120-BIB0010|tri12120-cit-0010","first-page":"88","article-title":"Combined liver-kidney transplantation: analysis of patients with preformed lymphocytotoxic antibodies","volume":"20","author":"Fung","year":"1988","journal-title":"Transplant Proc"},{"key":"10.1111\/tri.12120-BIB0011|tri12120-cit-0011","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1111\/j.1600-6143.2012.03995.x","article-title":"Prevalence, course and impact of HLA donor-specific antibodies in liver transplantation in the first year","volume":"12","author":"Taner","year":"2012","journal-title":"Am J Transplant"},{"key":"10.1111\/tri.12120-BIB0012|tri12120-cit-0012","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1111\/j.1399-0012.1997.tb00788.x","article-title":"Soluble fraction of class I human histocompatibility leukocyte antigens in the serum of liver transplant recipients","volume":"11","author":"McMillan","year":"1997","journal-title":"Clin Transplant"},{"key":"10.1111\/tri.12120-BIB0013|tri12120-cit-0013","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1111\/j.1600-6143.2011.03467.x","article-title":"Donor-directed MHC class I antibody is preferentially cleared from sensitized recipients of combined liver\/kidney transplants","volume":"11","author":"Dar","year":"2011","journal-title":"Am J Transplant"},{"key":"10.1111\/tri.12120-BIB0014|tri12120-cit-0014","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1097\/00007890-198802000-00030","article-title":"Analysis of sequential changes in major histocompatibility complex expression in human liver grafts after transplantation","volume":"45","author":"Steinhoff","year":"1988","journal-title":"Transplantation"},{"key":"10.1111\/tri.12120-BIB0015|tri12120-cit-0015","doi-asserted-by":"crossref","first-page":"54","DOI":"10.3109\/00365529008999209","article-title":"Distribution of HLA-DR, HLA-DP, HLA-DQ antigens in liver tissue from patients with primary sclerosing cholangitis","volume":"25","author":"Broome","year":"1990","journal-title":"Scand J Gastroenterol"},{"key":"10.1111\/tri.12120-BIB0016|tri12120-cit-0016","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1097\/TP.0b013e3182543950","article-title":"De novo DQ donor-specific antibodies are associated with a significant risk of antibody-mediated rejection and transplant glomerulopathy","volume":"94","author":"Willicombe","year":"2012","journal-title":"Transplantation"},{"key":"10.1111\/tri.12120-BIB0017|tri12120-cit-0017","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1681\/ASN.2009101065","article-title":"Preexisting donor-specific HLA antibodies predict outcome in kidney transplantation","volume":"21","author":"Lefaucheur","year":"2010","journal-title":"J Am Soc Nephrol"},{"key":"10.1111\/tri.12120-BIB0018|tri12120-cit-0018","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1097\/TP.0b013e3181e36e08","article-title":"Donor-specific antibody levels and three generations of crossmatches to predict antibody-mediated rejection in kidney transplantation","volume":"90","author":"Riethmuller","year":"2010","journal-title":"Transplantation"},{"key":"10.1111\/tri.12120-BIB0019|tri12120-cit-0019","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1097\/TP.0b013e3182100f77","article-title":"No association of kidney graft loss with human leukocyte antigen antibodies detected exclusively by sensitive Luminex single-antigen testing: a collaborative transplant study report","volume":"91","author":"Susal","year":"2011","journal-title":"Transplantation"},{"key":"10.1111\/tri.12120-BIB0020|tri12120-cit-0020","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1007\/s10157-010-0387-8","article-title":"Rituximab in the treatment of acute cellular rejection of renal allograft with CD20-positive clusters in the infiltrate","volume":"15","author":"Vega","year":"2011","journal-title":"Clin Exp Nephrol"},{"key":"10.1111\/tri.12120-BIB0021|tri12120-cit-0021","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1097\/TP.0b013e3181da1cc3","article-title":"Combined posttransplant prophylactic IVIg\/anti-CD 20\/plasmapheresis in kidney recipients with preformed donor-specific antibodies: a pilot study","volume":"89","author":"Loupy","year":"2010","journal-title":"Transplantation"},{"key":"10.1111\/tri.12120-BIB0022|tri12120-cit-0022","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1111\/j.1432-2277.2012.01447.x","article-title":"Living donor kidney transplantation in crossmatch-positive patients enabled by peritransplant immunoadsorption and anti-CD20 therapy","volume":"25","author":"Morath","year":"2012","journal-title":"Transpl Int"},{"key":"10.1111\/tri.12120-BIB0023|tri12120-cit-0023","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1016\/j.transproceed.2012.01.109","article-title":"The role of splenectomy in the setting of refractory humoral rejection after kidney transplantation","volume":"44","author":"Tzvetanov","year":"2012","journal-title":"Transplant Proc"},{"key":"10.1111\/tri.12120-BIB0024|tri12120-cit-0024","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1097\/TP.0b013e318190af83","article-title":"Bortezomib provides effective therapy for antibody- and cell-mediated acute rejection","volume":"86","author":"Everly","year":"2008","journal-title":"Transplantation"},{"key":"10.1111\/tri.12120-BIB0025|tri12120-cit-0025","doi-asserted-by":"crossref","first-page":"2526","DOI":"10.1111\/j.1600-6143.2012.04126.x","article-title":"Bortezomib for acute antibody-mediated rejection in liver transplantation","volume":"12","author":"Paterno","year":"2012","journal-title":"Am J Transplant"},{"key":"10.1111\/tri.12120-BIB0026|tri12120-cit-0026","doi-asserted-by":"crossref","first-page":"246","DOI":"10.5414\/CN107156","article-title":"Proteasome inhibition with bortezomib: an effective therapy for severe antibody mediated rejection after renal transplantation","volume":"77","author":"Sureshkumar","year":"2012","journal-title":"Clin Nephrol"},{"key":"10.1111\/tri.12120-BIB0027|tri12120-cit-0027","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1111\/j.1600-6143.2006.01632.x","article-title":"The effect of desensitization protocols on human splenic B-cell populations in vivo","volume":"7","author":"Ramos","year":"2007","journal-title":"Am J Transplant"},{"key":"10.1111\/tri.12120-BIB0028|tri12120-cit-0028","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/j.1600-6143.2008.02461.x","article-title":"Proteasome inhibition causes apoptosis of normal human plasma cells preventing alloantibody production","volume":"9","author":"Perry","year":"2009","journal-title":"Am J Transplant"}],"container-title":["Transplant International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Ftri.12120","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/tri.12120\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T06:42:13Z","timestamp":1745995333000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/tri.12120"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5,15]]},"references-count":28,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2013,8]]}},"URL":"https:\/\/doi.org\/10.1111\/tri.12120","relation":{},"ISSN":["0934-0874"],"issn-type":[{"type":"print","value":"0934-0874"}],"subject":[],"published":{"date-parts":[[2013,5,15]]}}}